Biventricular or Conduction System Pacing for Cardiac Resynchronization Therapy: A Strategy for Cardiac

Amato Santoro1, Federico Landra2, Carmine Marallo2

  • 1Division of Cardiology, Azienda Ospedaliera Universitaria Senese, Viale Bracci 1, 53100 Siena, Italy.

Insights

A new algorithm using interventricular conduction delays (IVCD) guides cardiac resynchronization therapy (CRT) choices between biventricular pacing (BiVP) and conduction system pacing (CSP). This approach reduced adverse cardiovascular events by guiding the selection of pacing methods.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Cardiac resynchronization therapy (CRT) traditionally uses biventricular pacing (BiVP).
  • Conduction system pacing (CSP) is an emerging alternative, particularly when BiVP is challenging or fails.
  • Interventricular conduction delays (IVCD) are key indicators for pacing strategy selection.

Purpose of the Study:

  • To develop and evaluate a treatment algorithm for selecting between BiVP and CSP based on IVCD.
  • To compare the efficacy of the IVCD-guided algorithm against standard CRT practices.

Main Methods:

  • Prospective enrollment of 160 patients (delays-guided resynchronization group, DRG) using the IVCD algorithm from 2018-2020.
  • Comparison with a historical cohort of 132 patients (resynchronization standard guide group, SRG) treated from 2016-2017.
  • Primary endpoint: composite of cardiovascular mortality, heart failure hospitalization, or HF event at 1 year post-intervention.

Main Results:

  • The IVCD algorithm guided 25.6% of DRG patients to CSP.
  • The primary endpoint occurred in 21.8% of the DRG versus 36.4% in the SRG (HR: 1.72; 95% CI: 1.12-2.65; p=0.013).
  • The delays-guided resynchronization group demonstrated a significantly lower rate of adverse cardiovascular outcomes.

Conclusions:

  • An IVCD-based algorithm effectively redirected approximately one in four patients from BiVP to CSP.
  • This strategy led to a significant reduction in major adverse cardiovascular events post-implantation.
  • The IVCD algorithm is a valuable tool for optimizing CRT strategy selection between BiVP and CSP.
Abstract

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
861
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
9.4K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
19